The Orion Group is reforming its organisational structure to better reflect the development and growth of the company in line with its strategy. The new organisational structure is also reflected in changes to the Group Executive Management Board and its members' areas of responsibility. The new organisational structure and changes to the Executive Management Board will take effect from 1 January 2023.

Changes in the Orion Executive Management Board: Satu Ahomäki,M.Sc. (Econ.), has been appointed Senior Vice President of the Generics and Consumer Health business division as of 1 January 2023. Virve Laitinen, M.Sc.

(Tech.), MBA, has been appointed Senior Vice President of the Corporate Strategy and Program Management group level function as of 1 January 2023. She will be responsible for Orion's strategy process, corporate program management and information management. Niclas Lindstedt, M.Sc.

(Chem. Eng.), EMBA, has been appointed Senior Vice President of the Animal Health business division and a new member of the Orion Group Executive Management Board as of 1 January 2023. He has worked for Orion since 2003 in sales and marketing management positions and has been Vice President, Animal Health since 2010.

Hao Pan,M.Sc. (International Business), has been appointed Senior Vice President of the Branded Products business division and a new member of the Orion Group Executive Management Board as of 1 January 2023. He has worked for Orion since 2002 in various sales and marketing management positions in Orion's European sales organisation.

Outi Vaarala, PhD, MD, Professor, has been appointed Senior Vice President of the Innovative Medicines business division as of 1 January 2023. Vaarala will also continue in her role as Senior Vice President of Research & Development. Orion Group Executive Management Board as of 1 January 2023: Liisa Hurme, President and CEO; Satu Ahomäki, Senior Vice President, Generics and Consumer Health; Olli Huotari, Senior Vice President, Corporate Functions; Juhani Kankaanpää, Senior Vice President, Global Operations, Fermion Jari Karlson, Chief Financial Officer; Virve Laitinen, Senior Vice President, Corporate Strategy and Program Management; Niclas Lindstedt, Senior Vice President, Animal Health; Hao Pan, Senior Vice President, Branded Products; Outi Vaarala, Senior Vice President, Innovative Medicines and Research & Development.